Global Pricing and Market Access Hurdles for Innovation
In a recent keynote address at the 2021 EPP Life Sciences Pricing Conference, Alan Crowther, General Manager, EVERSANA Pricing and Market Access, discusses 4 hurdles that are serving as obstacles to innovation in global pricing and market access including:
- Increased pricing pressures
- Changing launch dynamics that impact patient access
- More complex global pricing dynamics
- Rise and changes in HTA
During this session, learn how increased global collaboration can serve as a key component in solving these challenges.
WATCH NOW:
Author
Alan has spent close to 20 years doing commercial work for the life sciences industry. His experience includes creating innovative solutions for global pricing and access, including work on price optimization, global data collection…